Anpario (LON:ANP) to Repurchase 0 Shares

Anpario (LON:ANP) announced that its board has authorized a share buyback program on Monday, April 27th, RTT News reports. The company plans to buyback 0 shares. This buyback authorization permits the company to purchase shares of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s management believes its stock is undervalued.

Anpario Stock Up 1.9%

Shares of LON:ANP traded up GBX 9 during trading on Monday, hitting GBX 494. The stock had a trading volume of 133,759 shares, compared to its average volume of 47,109. Anpario has a 12 month low of GBX 370 and a 12 month high of GBX 580. The company has a market capitalization of £83.71 million, a PE ratio of 13.02 and a beta of 0.99. The firm’s fifty day moving average is GBX 488.17 and its 200 day moving average is GBX 494.84. The company has a quick ratio of 5.16, a current ratio of 4.50 and a debt-to-equity ratio of 0.60.

Analyst Ratings Changes

A number of analysts have recently weighed in on the stock. Canaccord Genuity Group upgraded shares of Anpario to a “buy” rating and increased their target price for the stock from GBX 457 to GBX 570 in a report on Thursday, April 2nd. Shore Capital Group reiterated a “house stock” rating on shares of Anpario in a report on Monday. One equities research analyst has rated the stock with a Buy rating, According to data from MarketBeat, Anpario presently has a consensus rating of “Buy” and an average target price of GBX 570.

About Anpario

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.